Vesey Street Capital Partners Announces Recapitalization of Elite Body Sculpture

veseystreet

Vesey Street Capital Partners, a New York-based healthcare services private equity firm, announced that funds managed by VSCP have completed a recapitalization of Elite Body Sculpture (“EBS” or the “Company”), a founder-led, innovative physician services business that is a leading provider of minimally invasive body sculpting procedures. continue reading

HealthChannels Announces Acquisition of Texas-Based PhysAssist Scribes

veseystreet

HealthChannels, parent company to ScribeAmerica, the industry’s leading provider of medical scribes, expands its operations with the latest acquisition of PhysAssist Scribes. HealthChannels is pleased to announce the acquisition of PhysAssist Medical Scribes. The Texas-based medical scribe company has grown strategically, training medical scribes on EMR documentation support and provider efficiency for over-burdened hospitals and health systems. The acquisition will …

ScribeAmerica Appears on the Inc. 500|5000 List for Eighth Consecutive Year

veseystreet

ScribeAmerica, a subsidiary of HealthChannels, has been recognized by Inc. magazine as one of the nation’s fastest-growing private companies. The company ranks number 2,051 on the 2018 Inc. 500|5000 list with 217% growth over the past 3 years. FORT LAUDERDALE, Florida – August 15, 2018 – ScribeAmerica, the nation’s most frequently used medical scribe company, has earned a place on the Inc. magazine …

PE Hub: Vesey Street’s second fund sets sights on $200 mln

veseystreet

– NY sponsor invests in healthcare services companies generating Ebitda of $10 mln to $25 mln – PE shop founded in 2014 by Adam Feinstein, former LabCorp and Lehman Brothers exec – Vesey scored >10x its investment on Imedix, first full exit, in September Vesey Street Capital Partners, the healthcare-services firm run by a group of former Lehman Brothers executives, is …

VSCP Marks First Full Exit with Sale of Imedex

veseystreet

– Healthcare PE firm bought Imedex in 2015 – Vesey targets companies generating $10 mln-$25 mln EBITDA – Acquirer HMP preempted a formal sales process Vesey Street Capital Partners stands to make more than 10x its investment through the sale of Imedex, its first full exit, Buyouts has learned. Healthcare-services-focused Vesey sold Imedex just two years after buying the provider of …

Vesey Street Capital Partners Announces Sale of Imedex

veseystreet

New York, NY–(September 5, 2017) Vesey Street Capital Partners, LLC (VSCP) announced today that it sold Imedex, LLC an industry leader in the creation of independent, accredited medical education to HMP, a leading healthcare education and events company. Terms of the agreement were not disclosed.   “Since our acquisition of Imedex in 2015, we and our Board worked hard with …

Medical Scribes Improve Doctor-Patient Interaction

veseystreet

[ SEE EXTERNAL LINK FOR VIDEO ] Last time you went to the doctor, were you happy with the amount of time your doctor spent with you? Probably not. That’s the most common complaint patients have. CBS2’s Dr. Max Gomez explains how medical “scribes” have been helping.  Malik Hooker Jersey

ScribeAmerica Named to Inc. 500|5000 List for Seventh Consecutive Year

veseystreet

(PRWEB) AUGUST 16, 2017 ScribeAmerica, the nation’s most frequently used medical scribe company, has been recognized as one of America’s fastest growing private companies by Inc. magazine. Ranked number 1,461 overall in 2017, this year’s Inc. 500|5000 inclusion marks the seventh consecutive year ScribeAmerica has been honored by the magazine. As ScribeAmerica has grown over the past 14 years, the medical …

World’s Largest Gastrointestinal Cancer Congress to Highlight Advances and the Future of Care

veseystreet

The ESMO World Congress on Gastrointestinal Cancer, organized by Imedex, attracts more than 3,500 oncology professionals and researchers from around the globe. BARCELONA, SPAIN (PRWEB) JUNE 08, 2017 What does the future hold for the prevention and care of patients with gastrointestinal cancers? The answer to this question and more will be highlighted from 28 June to 1 July at …